Hypertriglyceridemia: From Biochemical Aberration to Cardiometabolic Syndrome - Emerging Pathophysiology, Clinical Challenges, and Novel Therapeutics . (2025). Diabzen, 3(2), 11-15. https://www.thediabzen.com/index.php/d/article/view/12